UnitedHealthcare Adds Deductibles to Medicare Part D for 2025
Oct 3, 2024 · Regulatory officials have identified 82 cases worldwide from the FDA Adverse Event Reporting System of anaphylaxis associated with the use of Coxapone and the generic Glatopa that have resulted in hospitalization or death.
Lilly Introduces Zepbound Single-Dose Vial for Cash-Paying Patients
Aug 27, 2024 · “In a clinical study, the 5 mg maintenance dose helped patients achieve an average of 15% weight loss after 72 weeks of treatment and has been a powerful tool for millions of people with obesity looking to lose weight and keep it off,” Patrik Jonsson, executive vice president, and president of Lilly Cardiometabolic Health and Lilly USA, said in a news release.
Medication underdosing and underprescribing: important issues …
Jun 1, 2013 · Medication underdosing and underprescribing are often overlooked and can result in poor patient outcomes. They can also contribute to polypharmacy and significant cost to the healthcare system. Pharmacists can play a key role in preventing underdosing and underprescribing of medications by ensuring that patient-specific pharmacotherapy is prescribed and administered, and by providing patient ...
Express Scripts and Cigna Add Zepbound to Formularies
Effective Dec. 1, 2023, Lilly’s Zepbound (tirzepatide) was added to the national preferred formulary for Express Scripts and Cigna Healthcare.
Beyond the Big Three PBMs - Managed Healthcare Executive
Dec 19, 2022 · By almost any measure, the PBM business is one dominated by the major players. In 2021, CVS Caremark led the industry, controlling 34% of total adjusted claims, followed by Express Scripts (25%) and Optum Rx (21%).
Alhemo Once-Daily Treatment for Hemophilia A, B with Inhibitors …
Dec 23, 2024 · The FDA recently approved Novo Nordisk’s Alhemo (concizumab-mtci), the first subcutaneous, once-daily treatment for hemophilia A or B with inhibitors, designed to prevent or reduce bleeding episodes in patients aged 12 and older.
CVS Caremark Makes Changes in Diabetes Coverage for 2025
Nov 25, 2024 · CVS Caremark has removed several diabetes drugs favor of newer products and generics, and is even favoring an insulin infusion system developed by a company that was cofounded by Alan Lotvin, a former executive at CVS Health.
Over 50 Biosimilars in 10 years — and the Pipeline is Still Full
As we pass 2024’s midpoint, 53 biosimilars have been approved in the United States; of those, 42 are now on the market. Those totals were reached 14 years after the pathway for these lower-cost biologics was created as part of the Affordable Care Act (ACA).
How Capitation Contracts Benefit Providers, Payers and Patients
May 11, 2023 · The Covid-19 pandemic triggered a dramatic decline in patient volume that devastated revenues for provider organizations operating under the fee-for-service (FFS) reimbursement model. In response, more provider organizations have adopted alternative payment models (APM) built around financial incentives to efficiently deliver high-quality care.
UnitedHealth Group Is Target of DOJ Antirust Investigation, …
Feb 27, 2024 · The Department of Justice has started an antitrust investigation of the UnitedHealth Group, the Wall Street Journal is reporting.. UnitedHealth Group, which is headquartered in suburban Minneapolis, comprises the health insurer UnitedHealthcare and Optum, which owns and operates doctors’ practices; a pharmacy benefit manager, Optum Rx, and a large number of other healthcare businesses.